Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis

Rossella Tricarico, Salvatore Cortellino, Antonio Riccio, Shantie Jagmohan-Changur, Heleen Van der Klift, Juul Wijnen, David Turner, Andrea Ventura, Valentina Rovella, Antonio Percesepe, Emanuela Lucci-Cordisco, Paolo Radice, Lucio Bertario, Monica Pedroni, Maurizio Ponz de Leon, Pietro Mancuso, Karthik Devarajan, Kathy Q. Cai, Andres J P Klein-Szanto, Giovanni Neri & 5 others Pål Møller, Alessandra Viel, Maurizio Genuardi, Riccardo Fodde, Alfonso Bellacosa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The DNA glycosylase gene MBD4 safeguards genomic stability at CpG sites and is frequently mutated at coding poly-A tracks in mismatch repair (MMR)-defective colorectal tumors (CRC). Mbd4 biallelic inactivation in mice provided conflicting results as to its role in tumorigenesis. Thus, it is unclear whether MBD4 alterations are only secondary to MMR defects without functional consequences or can contribute to the mutator phenotype. We investigated MBD4 variants in a large series of hereditary/familial and sporadic CRC cases. Whereas MBD4 frameshifts were only detected in tumors, missense variants were found in both normal and tumor DNA. In CRC with double-MBD4/MMR and single-MBD4 variants, transition mutation frequency was increased, indicating that MBD4 defects may affect the mutational landscape independently of MMR defect. Mbd4-deficient mice showed reduced survival when combined with Mlh1-/- genotype. Taken together, these data suggest that MBD4 inactivation may contribute to tumorigenesis, acting as a modifier of MMR-deficient cancer phenotype.

Original languageEnglish
Pages (from-to)42892-42904
Number of pages13
JournalOncotarget
Volume6
Issue number40
DOIs
Publication statusPublished - 2015

Fingerprint

DNA Mismatch Repair
Carcinogenesis
Colorectal Neoplasms
DNA Glycosylases
Phenotype
Neoplasms
Poly A
Genomic Instability
Mutation Rate
Genotype
DNA
Genes

Keywords

  • Colorectal cancer
  • HNPCC
  • MBD4/MED1
  • Mismatch repair
  • Mutations

ASJC Scopus subject areas

  • Oncology

Cite this

Tricarico, R., Cortellino, S., Riccio, A., Jagmohan-Changur, S., Van der Klift, H., Wijnen, J., ... Bellacosa, A. (2015). Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget, 6(40), 42892-42904. https://doi.org/10.18632/oncotarget.5740

Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. / Tricarico, Rossella; Cortellino, Salvatore; Riccio, Antonio; Jagmohan-Changur, Shantie; Van der Klift, Heleen; Wijnen, Juul; Turner, David; Ventura, Andrea; Rovella, Valentina; Percesepe, Antonio; Lucci-Cordisco, Emanuela; Radice, Paolo; Bertario, Lucio; Pedroni, Monica; de Leon, Maurizio Ponz; Mancuso, Pietro; Devarajan, Karthik; Cai, Kathy Q.; Klein-Szanto, Andres J P; Neri, Giovanni; Møller, Pål; Viel, Alessandra; Genuardi, Maurizio; Fodde, Riccardo; Bellacosa, Alfonso.

In: Oncotarget, Vol. 6, No. 40, 2015, p. 42892-42904.

Research output: Contribution to journalArticle

Tricarico, R, Cortellino, S, Riccio, A, Jagmohan-Changur, S, Van der Klift, H, Wijnen, J, Turner, D, Ventura, A, Rovella, V, Percesepe, A, Lucci-Cordisco, E, Radice, P, Bertario, L, Pedroni, M, de Leon, MP, Mancuso, P, Devarajan, K, Cai, KQ, Klein-Szanto, AJP, Neri, G, Møller, P, Viel, A, Genuardi, M, Fodde, R & Bellacosa, A 2015, 'Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis', Oncotarget, vol. 6, no. 40, pp. 42892-42904. https://doi.org/10.18632/oncotarget.5740
Tricarico R, Cortellino S, Riccio A, Jagmohan-Changur S, Van der Klift H, Wijnen J et al. Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget. 2015;6(40):42892-42904. https://doi.org/10.18632/oncotarget.5740
Tricarico, Rossella ; Cortellino, Salvatore ; Riccio, Antonio ; Jagmohan-Changur, Shantie ; Van der Klift, Heleen ; Wijnen, Juul ; Turner, David ; Ventura, Andrea ; Rovella, Valentina ; Percesepe, Antonio ; Lucci-Cordisco, Emanuela ; Radice, Paolo ; Bertario, Lucio ; Pedroni, Monica ; de Leon, Maurizio Ponz ; Mancuso, Pietro ; Devarajan, Karthik ; Cai, Kathy Q. ; Klein-Szanto, Andres J P ; Neri, Giovanni ; Møller, Pål ; Viel, Alessandra ; Genuardi, Maurizio ; Fodde, Riccardo ; Bellacosa, Alfonso. / Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. In: Oncotarget. 2015 ; Vol. 6, No. 40. pp. 42892-42904.
@article{e466e4c60e504aad90033fbb10231e7b,
title = "Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis",
abstract = "The DNA glycosylase gene MBD4 safeguards genomic stability at CpG sites and is frequently mutated at coding poly-A tracks in mismatch repair (MMR)-defective colorectal tumors (CRC). Mbd4 biallelic inactivation in mice provided conflicting results as to its role in tumorigenesis. Thus, it is unclear whether MBD4 alterations are only secondary to MMR defects without functional consequences or can contribute to the mutator phenotype. We investigated MBD4 variants in a large series of hereditary/familial and sporadic CRC cases. Whereas MBD4 frameshifts were only detected in tumors, missense variants were found in both normal and tumor DNA. In CRC with double-MBD4/MMR and single-MBD4 variants, transition mutation frequency was increased, indicating that MBD4 defects may affect the mutational landscape independently of MMR defect. Mbd4-deficient mice showed reduced survival when combined with Mlh1-/- genotype. Taken together, these data suggest that MBD4 inactivation may contribute to tumorigenesis, acting as a modifier of MMR-deficient cancer phenotype.",
keywords = "Colorectal cancer, HNPCC, MBD4/MED1, Mismatch repair, Mutations",
author = "Rossella Tricarico and Salvatore Cortellino and Antonio Riccio and Shantie Jagmohan-Changur and {Van der Klift}, Heleen and Juul Wijnen and David Turner and Andrea Ventura and Valentina Rovella and Antonio Percesepe and Emanuela Lucci-Cordisco and Paolo Radice and Lucio Bertario and Monica Pedroni and {de Leon}, {Maurizio Ponz} and Pietro Mancuso and Karthik Devarajan and Cai, {Kathy Q.} and Klein-Szanto, {Andres J P} and Giovanni Neri and P{\aa}l M{\o}ller and Alessandra Viel and Maurizio Genuardi and Riccardo Fodde and Alfonso Bellacosa",
year = "2015",
doi = "10.18632/oncotarget.5740",
language = "English",
volume = "6",
pages = "42892--42904",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "40",

}

TY - JOUR

T1 - Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis

AU - Tricarico, Rossella

AU - Cortellino, Salvatore

AU - Riccio, Antonio

AU - Jagmohan-Changur, Shantie

AU - Van der Klift, Heleen

AU - Wijnen, Juul

AU - Turner, David

AU - Ventura, Andrea

AU - Rovella, Valentina

AU - Percesepe, Antonio

AU - Lucci-Cordisco, Emanuela

AU - Radice, Paolo

AU - Bertario, Lucio

AU - Pedroni, Monica

AU - de Leon, Maurizio Ponz

AU - Mancuso, Pietro

AU - Devarajan, Karthik

AU - Cai, Kathy Q.

AU - Klein-Szanto, Andres J P

AU - Neri, Giovanni

AU - Møller, Pål

AU - Viel, Alessandra

AU - Genuardi, Maurizio

AU - Fodde, Riccardo

AU - Bellacosa, Alfonso

PY - 2015

Y1 - 2015

N2 - The DNA glycosylase gene MBD4 safeguards genomic stability at CpG sites and is frequently mutated at coding poly-A tracks in mismatch repair (MMR)-defective colorectal tumors (CRC). Mbd4 biallelic inactivation in mice provided conflicting results as to its role in tumorigenesis. Thus, it is unclear whether MBD4 alterations are only secondary to MMR defects without functional consequences or can contribute to the mutator phenotype. We investigated MBD4 variants in a large series of hereditary/familial and sporadic CRC cases. Whereas MBD4 frameshifts were only detected in tumors, missense variants were found in both normal and tumor DNA. In CRC with double-MBD4/MMR and single-MBD4 variants, transition mutation frequency was increased, indicating that MBD4 defects may affect the mutational landscape independently of MMR defect. Mbd4-deficient mice showed reduced survival when combined with Mlh1-/- genotype. Taken together, these data suggest that MBD4 inactivation may contribute to tumorigenesis, acting as a modifier of MMR-deficient cancer phenotype.

AB - The DNA glycosylase gene MBD4 safeguards genomic stability at CpG sites and is frequently mutated at coding poly-A tracks in mismatch repair (MMR)-defective colorectal tumors (CRC). Mbd4 biallelic inactivation in mice provided conflicting results as to its role in tumorigenesis. Thus, it is unclear whether MBD4 alterations are only secondary to MMR defects without functional consequences or can contribute to the mutator phenotype. We investigated MBD4 variants in a large series of hereditary/familial and sporadic CRC cases. Whereas MBD4 frameshifts were only detected in tumors, missense variants were found in both normal and tumor DNA. In CRC with double-MBD4/MMR and single-MBD4 variants, transition mutation frequency was increased, indicating that MBD4 defects may affect the mutational landscape independently of MMR defect. Mbd4-deficient mice showed reduced survival when combined with Mlh1-/- genotype. Taken together, these data suggest that MBD4 inactivation may contribute to tumorigenesis, acting as a modifier of MMR-deficient cancer phenotype.

KW - Colorectal cancer

KW - HNPCC

KW - MBD4/MED1

KW - Mismatch repair

KW - Mutations

UR - http://www.scopus.com/inward/record.url?scp=84952359728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952359728&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.5740

DO - 10.18632/oncotarget.5740

M3 - Article

VL - 6

SP - 42892

EP - 42904

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 40

ER -